Cord Dohrmann
Administration
EternygenÂ
Germany
Biography
Cord Dohrmann joined Evotec AG as Chief Scientific Officer and Member of the Management Board on 01 September 2010. Dr Dohrmann has spent over 20 years in biomedical research at leading academic institutions and in the biotech industry. Prior to Evotec he started his career as a Shiseido as a research fellow at the Massachusetts General Hospital in Boston before joining DeveloGen in 1999. He served the company in various management positions including CEO, leading DeveloGen from a start-up to an internationally recognised metabolic disease company with a pipeline of highly innovative preclinical and clinical products for the treatment of diabetes and related disorders. Dohrmann has been advising the European Commission, the Max-Planck-Institute as well as various venture capital firms. He holds a degree from Tübingen University in Germany and conducted research as a DAAD scholar at Duke University, Durham, USA. Dr. Dohrmann completed his MA thesis at the Max-Planck Institute in Tübingen and subsequently enrolled at the Harvard Medical School in Boston, USA, where he received his Ph.D. in 1996.
Research Interest
Molecular Biology
